Substrate‐mediated enhancement of phosphorylated tyrosine hydroxylase in nigrostriatal dopamine neurons: evidence for a role of α‐synuclein

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Neurochemistry

• Publication date

  2006-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1471-4159.2005.03606.xPMID 16412098
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.

  2004cited by this paper
• Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in Vivo using an inhibitor of the aromatic amino acid decarboxylase

  2004cited by this paper
• Changes of Dopamine Turnover in the Progression of Parkinson's Disease as Measured by Positron Emission Tomography: Their Relation to Disease-Compensatory Mechanisms

  2004cited by this paper
• Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.

  2004cited by this paper
• α‐Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease

  2004cited by this paper
• α-Synuclein Locus Triplication Causes Parkinson's Disease

  2003cited by this paper
• Staging of brain pathology related to sporadic Parkinson's disease.

  2003cited by this paper
• alpha-Synuclein locus triplication causes Parkinson's disease.

  2003cited by this paper
• Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinson disease.

  2002cited by this paper
• A Role for α-Synuclein in the Regulation of Dopamine Biosynthesis

  2002influential reference
• A role for alpha-synuclein in the regulation of dopamine biosynthesis.

  2002cited by this paper
• Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease.

  2002cited by this paper
• Muscarinic Receptor Stimulation Induces Translocation of an α-Synuclein Oligomer from Plasma Membrane to a Light Vesicle Fraction in Cytoplasm*

  2001cited by this paper
• Mice Lacking a-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine

  2000cited by this paper
• Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system.

  2000cited by this paper
• Endogenous DA‐mediated feedback inhibition of DA neurons: Involvement of both D1‐ and D2‐like receptors

  2000cited by this paper
• α-Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins

  1999cited by this paper
• Developmental expression of α-synuclein in rat hippocampus and cerebral cortex

  1999cited by this paper
• alpha-Synuclein shares physical and functional homology with 14-3-3 proteins.

  1999cited by this paper
• Developmental expression of alpha-synuclein in rat hippocampus and cerebral cortex.

  1999cited by this paper
• α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies

  1998cited by this paper
• S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.

  1998cited by this paper
• Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins.

  1998cited by this paper
• Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

  1998cited by this paper
• AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

  1998cited by this paper
• alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.

  1998cited by this paper
• A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity

  1998cited by this paper
• Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

  1997cited by this paper
• Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

  1997cited by this paper
• Intricate Regulation of Tyrosine Hydroxylase Activity and Gene Expression

  1996cited by this paper
• Characterization of a novel protein regulated during the critical period for song learning in the zebra finch.

  1995cited by this paper
• Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectively in the mesolimbic dopaminergic system

  1995cited by this paper
• Thermal stability and CD analysis of rat tyrosine hydroxylase.

  1995cited by this paper
• Identification of two distinct synucleins from human brain

  1994cited by this paper
• Microtubule-associated protein kinase-2 phosphorylates and activates tyrosine hydroxylase following depolarization of bovine adrenal chromaffin cells.

  1994cited by this paper
• Prazosin modulates the changes in firing pattern and transmitter release induced by raclopride in the mesolimbic, but not in the nigrostriatal dopaminergic system

  1994cited by this paper
• A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation.

  1993cited by this paper
• Phosphorylation and activation of human tyrosine hydroxylase in vitro by mitogen-activated protein (MAP) kinase and MAP-kinase-activated kinases 1 and 2.

  1993cited by this paper
• Site-directed mutagenesis of serine 40 of rat tyrosine hydroxylase. Effects of dopamine and cAMP-dependent phosphorylation on enzyme activity.

  1992cited by this paper
• ERK1 and ERK2, two microtubule-associated protein 2 kinases, mediate the phosphorylation of tyrosine hydroxylase at serine-31 in situ.

  1992cited by this paper
• Inactivation of tyrosine hydroxylase by pterin substrates following phosphorylation by cyclic AMP-dependent protein kinase.

  1990influential reference
• pH‐dependent release of catecholamines from tyrosine hydroxylase and the effect of phosphorylation of Ser‐40

  1990cited by this paper
• Phosphorylation of tyrosine hydroxylase in situ at serine 8, 19, 31, and 40.

  1990cited by this paper
• Identification of protein phosphatase 2A as the major tyrosine hydroxylase phosphatase in adrenal medulla and corpus striatum: evidence from the effects of okadaic acid

  1989cited by this paper
• Raclopride, a new selective ligand for the dopamine-D2 receptors.

  1988cited by this paper
• Identification of four phosphorylation sites in the N-terminal region of tyrosine hydroxylase.

  1986cited by this paper
• Characterization of the sites phosphorylated on tyrosine hydroxylase by Ca2+ and phospholipid‐dependent protein kinase, calmodulin‐dependent multiprotein kinase and cyclic AMP‐dependent protein kinase

  1985cited by this paper
• Calcium/phospholipid-dependent protein kinase (protein kinase C) phosphorylates and activates tyrosine hydroxylase.

  1984cited by this paper
• Phosphorylation of tyrosine hydroxylase by calmodulin-dependent multiprotein kinase.

  1984cited by this paper
• Tyrosine Hydroxylase Inactivation Following cAMP‐Dependent Phosphorylation Activation

  1983cited by this paper
• Thermal Denaturation of Native Striatal Tyrosine Hydroxylase: Increased Thermolability of the Phosphorylated Form of the Enzyme

  1981cited by this paper
• Tyrosine 3-monoxygenase is phosphorylated by Ca2+-, calmodulin-dependent protein kinase, followed by activation by activator protein.

  1981cited by this paper
• Tyrosine Hydroxylase Activation and Inactivation by Protein Phosphorylation Conditions

  1981cited by this paper
• Tyrosine availability and dopamine synthesis in the striatum: studies with gamma-butyrolactone.

  1981cited by this paper
• Tyrosine hydroxylase: studies on the phosphorylation of a purified preparation of the brain enzyme by the cyclic AMP-dependent protein kinase.

  1981cited by this paper
• Tyrosine hydroxylase: a substrate of cyclic AMP-dependent protein kinase.

  1980cited by this paper
• Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions.

  1980cited by this paper
• Tyrosine administration decreases serum prolactin levels in chronically reserpinized rats.

  1979cited by this paper
• In vitro phosphorylation of bovine adrenal tyrosine hydroxylase by adenosine 3':5'-monophosphate-dependent protein kinase.

  1979cited by this paper
• Direct phosphorylation of brain tyrosine hydroxylase by cyclic AMP-dependent protein kinase: mechanism of enzyme activation.

  1978cited by this paper
• ATP, cyclic AMP, and magnesium increase the affinity of rat striatal tyrosine hydroxylase for its cofactor.

  1975cited by this paper
• Isolated removal of hypothalamic or other brain nuclei of the rat.

  1973influential reference
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Regulation of tyrosine hydroxylase: relevance to Parkinson's disease

  2020cites this paper
• 9-Methyl-β-carboline inhibits monoamine oxidase activity and stimulates the expression of neurotrophic factors by astrocytes

  2020cites this paper
• Tyrosine hydroxylase phosphorylation in vivo

  2019cites this paper
• 10 Targeting Tyrosine Hydroxylase to Improve Bradykinesia

  2018cites this paper
• Beneficial Effects of Sesamol, Hesperidin, Quercetin and Phloroglucinol in Parkinson’s Disease Models- A Review

  2018cites this paper
• Complex molecular regulation of tyrosine hydroxylase

  2014cites this paper
• Avaliação da excursão diafragmática em um modelo experimental da doença de Parkinson

  2014cites this paper
• INTERACTION BETWEEN -SYNUCLEIN AND TAU PATHOLOGIES IN A MOUSE MODEL OF LEWY BODY DEMENTIA

  2012cites this paper
• Targeting Tyrosine Hydroxylase to Improve Bradykinesia

  2012cites this paper
• Different effects of intranigral and intrastriatal administration of the proteasome inhibitor lactacystin on typical neurochemical and histological markers of Parkinson's disease in rats.

  2011cites this paper
• Stimulation, protection and regeneration of dopaminergic neurons by 9-methyl-β-carboline: a new anti-Parkinson drug?

  2011cites this paper
• Investigation of immunization mechanisms in Lewy body disease

  2010cites this paper
• RNA interference mediated silencing of alpha-synuclein in MN9D cells and its effects on cell viability.

  2008cites this paper
• Silencing α-Synuclein Gene Expression Enhances Tyrosine Hydroxylase Activity in MN9D Cells

  2008cites this paper
• RNA interference mediated silencing of α-synuclein in MN9D cells and its effects on cell viability

  2008cites this paper
• Effects of Sildenafil on Nigrostriatal Dopamine Neurons in a Murine Model of Parkinson's Disease

  2008cites this paper
• α-Synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers

  2006cites this paper